Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE0005227235
Tue, 13.07.2021
Biotest AG
PRESS RELEASE
Biotest receives manufacturing license for new production facility and plans to hire 150 additional employees
- Final inspection by the Darmstadt Regional Council and the Paul Ehrlich Institute successfully completed
- Start of routine production and ramp-up of the plants is initiated
- 150 additional employees are sought
Dreieic [ … ]
Wed, 30.06.2021
Biotest AG
PRESS RELEASE
Biotest AG opens fifth plasma collection centre in Czech Republic
- 24 plasma collection centres in Europe to ensure long-term plasma supply
Dreieich, 30 June 2021. Biotest has received the operating license for its fifth plasma collection centre in Czech Republic from the country's national public health authority SUKL. The centre [ … ]
Wed, 02.06.2021
Biotest AG
PRESS RELEASE
Biotest successfully completes recruitment for its clinical trial with trimodulin in severe COVID-19 patients
- Trimodulin as potential life-saving treatment for severe COVID-19 patients
- All 166 trial patients treated by end of June, first results expected for August 2021
- Positive recommendation from Data Safety and Monitori [ … ]
Tue, 11.05.2021
Biotest AG
PRESS RELEASE
Biotest AG: Annual General Meeting approves dividend distribution
- Distribution of EUR 0.04 per preferred share
- Broad majority on all agenda items in accordance with the proposals of the management (Verwaltung)
Dreieich 11 May 2021. At the second ordinary, virtual Annual General Meeting on 11 May 2021, the shareholders of Biote [ … ]
Tue, 11.05.2021
Biotest AG
PRESS RELEASE
Biotest AG: Annual General Meeting approves dividend distribution
- Distribution of EUR 0.04 per preferred share
- Broad majority on all agenda items
Dreieich 11 May 2021. At the second ordinary, virtual Annual General Meeting on 11 May 2021, the shareholders of Biotest AG resolved to distribute a dividend. A total of 47.75 % of t [ … ]
Tue, 11.05.2021
Biotest AG
PRESS RELEASEBiotest increases sales by more than 22 % in the first quarter of 2021 to 120 million EUR
- Strong sales growth in Eastern and Southern Europe region
- EBIT burdened by product mix, plasma costs and increased hygiene expenses
- Forecast for 2021 confirmed
Dreieich, 11 May, 2021. The Biotest Group recorded revenue of € 120.0 million [ … ]
Thu, 06.05.2021
Biotest AG
PRESS RELEASE
Biotest AG opens 10th plasma collection centre in Hungary
- 23 plasma collection centres in Europe to ensure long-term plasma supply
Dreieich, 6 May 2021. Biotest received an operating permit for its 10th plasma collection centre in Hungary from the country's national public health authority OTH. The centre is located in the wester [ … ]
Thu, 22.04.2021
Biotest AG
PRESS RELEASE
Biotest confirms good tolerability and efficacy of Intratect(R) in primary and secondary immunodeficiencies in an observational study
- Proven reduction of infections in patients with secondary antibody deficiency
- Enhanced quality of life during treatment
- Good tolerability allows reduction of pre-medication
Dreieich, 22 Ap [ … ]
Wed, 07.04.2021
Biotest AG
PRESS RELEASE
Biotest accelerates fibrinogen phase III study with additional patient group
- First patient of this group treated successfully
- Important milestone for acceleration of the clinical development program for Fibrinogen
- Excellent efficacy and tolerability confirmed
- Results are the basis for the marketing authorization in Europe [ … ]
Wed, 31.03.2021
Biotest AG
PRESS RELEASE
Biotest exceeds Sales and EBIT forecast in the 2020 financial year
- Revenue forecast exeeded with revenue growth of 15.5%
- EBIT in core business very profitable at € 78.4 million
- Biotest invites to the virtual Annual General Meeting on 11 May, 2021
Dreieich, 31 March, 2021. In financial year 2020, the Biotest Group generated [ … ]